Diasorin Ltd
COMPANY INFORMATION
DiaSorin is an Italian multinational Group and a global leader in the market for in vitro diagnostics. DiaSorin is listed on the MTA (automated stock market) in the FTSE Italia Mid Cap Index, organized and managed by Borsa Italiana S.p.A
For over 40 years the Group has been developing, producing and commercializing diagnostic tests for a wide range of clinical areas. DiaSorin tests are designed for hospital and private testing laboratories, in the markets of immunodiagnostics and molecular diagnostics.
LATEST STORIES
PRODUCTS AND SERVICES
Latest Issues
Stago’s objective is to improve the health of as many people as possible by offering powerful biotechnology solutions for blood-based diagnostics.
We take a lean, confidence-building approach to digital connectivity – from our latest Coag.One middleware to our cyber-secure Connect.One capability for enhanced engineering and remote...
Microbe 2026
Crowne Plaza Hotel, Sheffield
9-11 October, 2026
UK NEQAS webinar: IHC Technical Issues and Quality Assurance
Online
13-15 October, 2026
Lab Innovations
NEC, Birmingham
4-5 November, 2026
UK NEQAS webinar: IHC Applications in Laboratory Practice
Online
10-12 November, 2026
BAC Annual Scientific Meeting
Newcastle upon Tyne
13 November, 2026